Crossmark Global Holdings’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$495K Buy
3,940
+338
+9% +$42.4K 0.01% 892
2025
Q1
$493K Sell
3,602
-585
-14% -$80.1K 0.01% 879
2024
Q4
$640K Sell
4,187
-2,870
-41% -$439K 0.01% 733
2024
Q3
$1.37M Sell
7,057
-394
-5% -$76.3K 0.02% 513
2024
Q2
$1.73M Sell
7,451
-1,807
-20% -$419K 0.03% 438
2024
Q1
$2M Sell
9,258
-269
-3% -$58K 0.04% 422
2023
Q4
$2.47M Sell
9,527
-2,255
-19% -$583K 0.05% 349
2023
Q3
$3.11M Sell
11,782
-11,265
-49% -$2.98M 0.07% 289
2023
Q2
$6.11M Sell
23,047
-835
-3% -$221K 0.13% 191
2023
Q1
$6.64M Buy
23,882
+712
+3% +$198K 0.16% 170
2022
Q4
$6.42M Buy
23,170
+4,602
+25% +$1.27M 0.16% 161
2022
Q3
$4.96M Buy
18,568
+699
+4% +$187K 0.14% 186
2022
Q2
$3.64M Sell
17,869
-319
-2% -$65.1K 0.09% 242
2022
Q1
$3.83M Buy
18,188
+5,687
+45% +$1.2M 0.09% 255
2021
Q4
$3M Buy
12,501
+2,555
+26% +$613K 0.07% 294
2021
Q3
$2.82M Buy
9,946
+1,232
+14% +$349K 0.07% 295
2021
Q2
$3.02M Sell
8,714
-1,371
-14% -$475K 0.07% 276
2021
Q1
$2.82M Sell
10,085
-632
-6% -$177K 0.07% 288
2020
Q4
$2.62M Buy
10,717
+195
+2% +$47.7K 0.07% 310
2020
Q3
$2.99M Sell
10,522
-177
-2% -$50.2K 0.08% 254
2020
Q2
$2.86M Sell
10,699
-675
-6% -$181K 0.08% 264
2020
Q1
$3.6M Sell
11,374
-462
-4% -$146K 0.13% 184
2019
Q4
$3.51M Sell
11,836
-2,307
-16% -$685K 0.1% 239
2019
Q3
$3.29M Sell
14,143
-963
-6% -$224K 0.1% 240
2019
Q2
$3.53M Buy
15,106
+946
+7% +$221K 0.1% 234
2019
Q1
$3.35M Sell
14,160
-286
-2% -$67.6K 0.1% 248
2018
Q4
$4.35M Buy
14,446
+743
+5% +$224K 0.13% 190
2018
Q3
$4.84M Sell
13,703
-1,037
-7% -$366K 0.12% 202
2018
Q2
$4.28M Sell
14,740
-1,706
-10% -$495K 0.11% 214
2018
Q1
$4.5M Buy
16,446
+1,059
+7% +$290K 0.12% 216
2017
Q4
$4.9M Sell
15,387
-1,133
-7% -$361K 0.12% 215
2017
Q3
$5.17M Buy
+16,520
New +$5.17M 0.13% 189
2016
Q3
$5.17M Buy
+16,520
New +$5.17M 0.13% 189